<DOC>
	<DOCNO>NCT00894699</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness study medication contain combination pain medication , sufentanil , sedative , triazolam . This drug design provide mild sedation well reduce anxiety pain procedure ( case elective abdominal liposuction ) .</brief_summary>
	<brief_title>A Study Evaluate Clinical Efficacy , Safety Tolerability ARX-F03 Sublingual Sufentanil/Triazolam NanoTab™ Patients Undergoing Elective Abdominal Liposuction Procedure</brief_title>
	<detailed_description />
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Triazolam</mesh_term>
	<criteria>1 . Patient must provide write informed consent participate study . 2 . Male female patient 18 60 ( inclusive ) year age . 3 . Patient plan undergo elective outpatient abdominal liposuction procedure . 4 . Patient must classify American Society Anesthesiologists ( ASA ) class I III . 5 . Patient must Body Mass Index [ BMI = weight ( kg ) /height ( m2 ) ] 20 35 , inclusively . 6 . Female patient childbearing potential must use effective method birth control time screen visit 30 day follow dose study medication . Acceptable method birth control include oral transdermal contraceptive , condom , spermicidal foam , intrauterine device ( IUD ) , progestin implant injection , abstinence , vaginal ring , sterilization partner . The reason nonchildbearing potential , bilateral tubal ligation , bilateral oophorectomy , hysterectomy , postmenopausal ≥1 year , must specify . Patients use hormonal form contraception must also willing use barrier method contraception screen 30 day follow dose study medication . 7 . Patient willing receive antibiotic per normal practice surgeon . 8 . Patient understands preoperative analgesic anxiolytic permit . 9 . Patient willing avoid caffeine alcohol use within 24 hour procedure . 10 . The patient must willing able understand study procedure use pain anxiety scale , communicate meaningfully study personnel . 11 . The patient must caregiver available escort patient home follow procedure . 1 . Patient expect require less 400 cc 700 cc abdominal fat removal procedure . 2 . Patient previously respond opioid analgesic treatment pain . 3 . Patient previously respond benzodiazepine treatment anxiety . 4 . Patient currently take opioid take opioid 7 consecutive day daily use within past 3 month prior procedure . 5 . Patient currently take benzodiazepine take benzodiazepine 7 consecutive day within past 3 month prior procedure . 6 . Patient take monoamine oxidase inhibitor ( MAOIs ) , take MAOIs within 14 day prior enrol study . 7 . Patient allergy hypersensitivity opioids . 8 . Patient currently take antiinflammatory drug , include steroid . 9 . Use drug P450 3A4 inducer inhibitor within 30 day dose include alprazolam , chlorpheniramine , cimetidine , fluoxetine , haloperidol , ketoconazole , itraconazole , erythromycin , clarithromycin , sildenafil , simvastatin , St. John 's Wort . 10 . Patient take calcium channel blocker beta blocker . 11 . Patient consume grapefruit , product make grapefruit , within 3 day study medication dose . 12 . Patient history chronic obstructive pulmonary disease ( COPD ) respiratory condition active pulmonary disease . 13 . Patient currently sleep apnea document sleep laboratory study . 14 . Patient woman pregnant lactating . 15 . Patient history anxiety disorder . 16 . Patients oral mucositis stomatitis . 17 . Patient history drug , prescription medicine , alcohol abuse within past 2 year . 18 . Patient use investigational drug device within 30 day screen visit . 19 . Patient undergone liposuction procedure previously . 20 . Patient history migraine chronic headache . 21 . Patient positive urine screen drug abuse screen day procedure . 22 . Patient positive alcohol screen day procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>procedural sedation</keyword>
</DOC>